Orionis Biosciences
PrivateLast Round
Corporate Funding
May 21, 2025
Total Funding Raised
$111M
Company Overview
Orionis Biosciences is a life sciences company that develops precision therapies for life-threatening diseases using its proprietary Allo-Glue and A-Kine technology platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orionis Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Orionis Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 21, 2025 | ||||
| Corporate Funding | Sep 20, 2023 | ||||
| Series C | Oct 19, 2022 | ||||
| Convertible Debt | Mar 5, 2020 | ||||
| Series B | Apr 1, 2018 | ||||
Series B | Mar 1, 2018 |
Orionis Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cormorant Asset Management | Series C |
| Cascade Investment | Series B |
| Genentech | Corporate Funding |
| Fidelity Management & Research Company | Series B |
| V-Bio Ventures | Series A |
| Excel Venture Management | Series A |
| Nextech Invest | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2025
Second multi-year deal valued at over $2 billion for molecular glue development.
- Oct 19, 2022
$55M round led by Cormorant Asset Management and Novartis.
Orionis Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orionis Biosciences's valuation, stock price, and market status.